Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Follow-up and Booster of FSME-IMMUN in Children
NCT00161967Phase 4Completed
- Sponsor
- Pfizer
- Start
- May 2005
- Primary completion
- Jul 2008
- Modality
- Whole Inactivated Vaccines
- Countries
- 3
01
Overview
A Phase 4 trial of FSME-IMMUN in tick-borne encephalitis (TBE), sponsored by Pfizer. Started May 2005; status: completed.
02
Drugs
FSME-IMMUN
03
Conditions
tick-borne encephalitis (TBE)
Beyond the preview
Go deeper on NCT00161967.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00161967.